Variant report
Variant | nsv887658 |
---|---|
Chromosome Location | chr7:13275578-13297072 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr7:13277363..13280042-chr7:13283075..13284729,2 | K562 | blood: | |
2 | chr7:12728492..12730623-chr7:13283814..13286718,2 | K562 | blood: | |
3 | chr7:13277363..13280042-chr7:13283075..13284729,2 | K562 | blood: | |
4 | chr7:12726407..12728675-chr7:13293795..13296695,2 | K562 | blood: | |
5 | chr7:13234533..13236633-chr7:13288975..13291281,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000122644 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs17166921 | chr7:13275578-13275579 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs185975954 | chr7:13275587-13275588 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs548279741 | chr7:13275616-13275617 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs561782384 | chr7:13275641-13275642 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs546571901 | chr7:13275644-13275645 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs527242797 | chr7:13275670-13275671 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs115345557 | chr7:13275684-13275685 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs566159395 | chr7:13275689-13275690 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs570401128 | chr7:13275712-13275713 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs539712371 | chr7:13275722-13275723 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs549844076 | chr7:13275767-13275768 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs138499247 | chr7:13275771-13275772 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs535291381 | chr7:13275776-13275777 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs116302041 | chr7:13275782-13275783 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs28493823 | chr7:13275789-13275790 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs568813000 | chr7:13275794-13275795 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs534070696 | chr7:13275801-13275802 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs144056111 | chr7:13275829-13275830 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs76611621 | chr7:13275891-13275892 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs546453336 | chr7:13275906-13275907 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs190560685 | chr7:13275931-13275932 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs181389695 | chr7:13275975-13275976 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs186326366 | chr7:13275982-13275983 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs542452436 | chr7:13275996-13275997 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs561719350 | chr7:13276016-13276017 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs16877758 | chr7:13276052-13276053 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs10488256 | chr7:13276061-13276062 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs564095488 | chr7:13276068-13276069 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs532819518 | chr7:13276090-13276091 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs13227738 | chr7:13276093-13276094 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs569870150 | chr7:13276119-13276120 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs7806310 | chr7:13276128-13276129 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
33 | rs147331062 | chr7:13276163-13276164 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs12699458 | chr7:13276189-13276190 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs577406528 | chr7:13276230-13276231 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs554001181 | chr7:13276232-13276233 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs137859470 | chr7:13276237-13276238 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs539862644 | chr7:13276310-13276311 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs546389706 | chr7:13276311-13276312 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs191225950 | chr7:13276340-13276341 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs367896616 | chr7:13276368-13276369 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs576812239 | chr7:13276376-13276377 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs182363172 | chr7:13276396-13276397 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs115395429 | chr7:13276409-13276410 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs141635873 | chr7:13276410-13276411 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs541108431 | chr7:13276416-13276417 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs12699459 | chr7:13276439-13276440 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs12699460 | chr7:13276444-13276445 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs111857473 | chr7:13276456-13276457 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs12699461 | chr7:13276497-13276498 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Biliary cancer | 19435499 | CNVD |
Cancer | 16751803 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Wilms tumour | 21544195 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Glioma | 21971842 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Oral cancer | 21386901 | CNVD |
colon cancer | 17210682 | CNVD |
Lung adenocarcinoma | 21810691 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Hypothalamic hamartomas | 18252217 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Leukemia | 23979775 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Autism | 22495311 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Melanoma | 17363583 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16272173 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Medulloblastoma | 17653508 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 19242612 | CNVD |
Autism | 18414403 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Cancer | 21637783 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16397240 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:13273600-13276200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
2 | chr7:13274600-13276200 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
3 | chr7:13274600-13276400 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
4 | chr7:13275200-13276400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
5 | chr7:13275400-13276400 | Enhancers | Cortex derived primary cultured neurospheres | brain |
6 | chr7:13275600-13276000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
7 | chr7:13275600-13276000 | Enhancers | Adipose Nuclei | Adipose |
8 | chr7:13276200-13279800 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
9 | chr7:13276200-13279800 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
10 | chr7:13279000-13279800 | Enhancers | A549 | lung |
11 | chr7:13279800-13280200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
12 | chr7:13279800-13280200 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
13 | chr7:13279800-13280200 | Enhancers | NH-A | brain |
14 | chr7:13279800-13280400 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
15 | chr7:13279800-13280400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
16 | chr7:13279800-13280400 | Flanking Active TSS | A549 | lung |
17 | chr7:13279800-13280600 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
18 | chr7:13280000-13280400 | Enhancers | H9 Cell Line | embryonic stem cell |
19 | chr7:13280000-13280400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
20 | chr7:13280000-13280400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
21 | chr7:13280000-13280400 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
22 | chr7:13280400-13280600 | Enhancers | A549 | lung |